Mutation and overexpression of the p53 gene have been noted in a wide range of human cancers and are thought to play a role in malignant transformation. Previously, immunohistochemical detection of p53 has been possible only in fresh-frozen tissues. We d e d p53 expression in pataffinembedded tissues from 50 epithelial ovatian cancers and 25 primary breast cancers with a modified immunohistochemical (MC) technique developed in this laboratory, using monoclonal antibody (MAb) PAbl801. The 75 cases were selected from a group of patients in whom the expression
Introduction
p53 is a 53 KD nuclear phosphoprotein which is expressed by many normal cells (1). Although p53 accumulates in the nucleus during S-phase of the cell cycle (2), the exact function of p53 in the regulation of cell proliferation in normal or neoplastic growth remains unknown. Nevertheless, it has been shown that the p53 gene, located on chromosome 17p, acquires mutations during the development of many human malignancies, including colon (3), breast (4), ovarian ( 5 ) . and lung (6) cancers. The p53 mutations that have been identified in these tumors are located in a region of the gene that has been highly conserved through evolution (7) . These mutations, which cause amino acid substitutions, appear to change the conformation of the p53 molecule, resulting in increased stability of the protein and a higher steady-state protein level within the cell (8) . Therefore, overexpression of p53 and mutation of the p53 gene are closely related events. This correlation has been demonstrated for breast (9) , lung (6) , ovarian ( 5 ) , endometrial (IO), and colorectal cancers (1 1).
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Correspondence It has been suggested that the loss of wild-type p53 function may play a role in malignant transformation. This loss may occur either by mutation of one copy of the p53 gene, followed by deletion of the remaining wild-type allele, or through inactivation of the wild-type protein after oligomerization with the more stable mutant protein (12) .
The p53 gene is the oncogene most frequently implicated in human cancer (13J4). Since a significant fraction of epithelial cancers contain a p53 mutation and/or deletion which leads to the overexpression of the protein, reliable techniques are needed to detect the mutant p53 proteins in clinical specimens. Many protooncogene and tumor suppressor gene products are destroyed by heating or formalin fixation and cannot be stained effectively in paraffin-embedded tissue. In the past, using published methodology, fresh-frozen tissue has been used for detection of p53 by monoclonal antibodies (MAb). MAb have also been successfully used on methacam-fixed, paraffin-embedded tissue; however, this is an uncommon fixative for archival material (15) . This limitation has hindered clinical studies of rare tumors and necessitates extra time and effort to obtain fresh tissue at the time of surgery. In view of these problems, we have developed a protocol for immunohistochemical detection of p53 in formalin-fixed, paraffinembedded tissues which have been fixed, embedded, and stored using routine hospital procedures. In this study, we demonstrate that this protocol detects p53 overexpression with the same effi-ciency as the more conventional technique employing cryopreserved specimens.
Materials and Methods
Fresh Tissues. Owian and breast cancers were obtained from patients at Duke University Medical Center between 1987 and 1991, according to procedures approved by the Institutional Review Baud. Sevcnty-five carcinomas (breast and m i a n ) were obtained: 49 serous and one mucinous epithelial warian cancer, and 22 invasive ductal and three carcinoma in situ of the breast. At the time of exploratory laparotomy or surgical resection, samples were examined grossly by a surgical pathologist for tumor infiltration and were flash-frozen in liquid nitrogen. Samples were stored at -135'C until assayed.
ParafXn Ti9ucs. Multiple archival paraffin blocks were obtained on each case from surgical pathology after the presence of cancer had been conf m e d . All tissues were fimd in 10% neutnl b&red formalin and processed by the D& Surgical Pathology Laboratory. Samples used in the fresh-tissue IHC and the paraffin IHC were obtained during the same surgical procedure and were procured from the same anatomic site.
AntiWcs. PAb1801 (Ab-2; Oncogene Science, Manhasset, NY) is an affinity-purified IgGi MAb antibody that recognizes a denaturationresistant epitope in the human p53 protein located between amino acids 32 and 79 (l6)This antibody was used at 1.0 pg/ml on parlffin-embedded tissues and at 0.5 pglml on fresh tissues. In each, serial sections were reacted with mouse IgGi (1.0 Fglml for paraffin assays and 0.5 pglml for fresh tissue assays) to assess nonspecific staining.
Fresh Tissue Preparation. Frozen tissue specimens were embedded in
OCT Compound (Ames Division; Miles Laboratories, Elkhut, IN) for thin sectioning in a cryostat microtome with a thermostat setting of -16T. Sections 4-6 pm thick were cut and placed on gelatinlpotassium dichromatecoated slides. Sections were air-dried overnight at room temperature and acetone-fixed for 10 min at room temperature. followed by an additional 30 min of drying before the beginning of the staining assay.
Pvaffin Tissue Preparation. Paraffin blocks were cooled in an ice-water mixture for 30 min before sectioning. Sections 4-6 pm thick were cut and placed on Histastick ( h a t e Chemical, Westbury, NY)-coated slides. After a brief drying period of approximately 15 min, the sections were heat-fixed to the slide at 37'C and stored at room temperature until the staining assay.
Fresh Tisue h m u a o h i s t o c h~.
The IHC method used in this study was modified from a previously published technique (17) . Slides were rinsed three times in PBS for 5 min each, followed by an incubation for 15 min in 5% normal horse serum (NHS) diluted in PBS/2% bovine serum albumin (BSA). The appropriately diluted primary antibody was then applied. Slides were incubated for 60 min at room temperature in a humidity chamber. Slides were then rinsed in PBS and subsequently incubated in the presence ofthe secondary antibody for 30 min at room temperature. The secondary antibody used was a biotinylatcd. & i t y -p d i e d horse anti-mouse IgG (Vector Laboratories; Burlingame, CA) used at a working dilution of k100 in 2% BSA. Slides were rinsed in PBS, followed by a 30-min incubation in pre-mixed Elite Universal Kit reagents as recommended by the product insert (Vector). Slides were washed three times in PBS and sections were developed in the enzyme substrate diaminobenzidine (DAB, Sigma, St Louis. MO) solution (100 mg 3,3'-diaminobenzidine, 200 mlO.05 M Tris buffcr, pH 7.6, 2 ml 0.6% H202). After chromogen development, slides were washed in running tapwater for 10 min and counterstained with 1% methyl green (Sigma) in sodium acetate b&r, pH 5.2. Slides were then dehydrated, cleared in xylene, and mounted in permanent coverslipping medium (Pro-TEXX, Baxter, McGaw Park IL).
Pulffin-embddd Immunohistochemistry. Slides were heated to 65°C in an Imperial 111 Incubator (Lab-Line; Melrose Park, IL) for 60 min. The slides were then taken directly from the incubator and deparaffinized in three changes of xylene for 5 min each, followed by three rinses in absolute ethanol (ETOH) for 2 min each. To eliminate staining due to endogenous peroxidase, sections were treated with an ETOHIH202 (45 ml ETOH13 ml HzOz) block for IO min at 4 2 C Slides were hydrated in decreasing concentrations of ethanol and rinsed in PBS. From this point in the assay, all antibody and complex incubations were carried out in a humidity chamber at 42'C. Slides were pre-incubated for 10 min in 5% NHS diluted in PBS/2% BSA, followed by an incubation for 45 min with primary antibody. Slides were then rinsed in PBS and subsequently incubated in the presence of the secondary antibody for 20 min. The secondary antibody was a biotinylated, affinity-purified horse anti-mouse IgG (Vector) used at a dilution of 1:lOO in PBSl2% BSA. Slides were rinsed in PBS, followed by a 20-min incubation in pre-mixed Elite Universal Kit rcagcnts as recommended by the product insert (Vector). The PBS rinse was repeated and sections were developed in the enzyme substrate DAB solution. From this step in the assay, treatment of paraffin-embedded and cryopreserved tissue was identical. mor were stained with PAbl801 when they were available. Discordant staining was occasionally observed in some tumors when the different blocks were compared. In seven cases where two or more blocks were stained, only one block demonstrated positive nuclear reactivity, and these were scored as positive in this study.
Results

Fifty
Expression of pS3 Protein in Epithelial Ovarian Cancer
Twenty-seven (54%) of the 50 ovarian cancers had strong nuclear staining in malignant epithelial cells in both the fresh-tissue and paraffin-tissue IHC assays (Table 1) . Twenty-one (42%) were negative for p53 in both assays. Overall, an identical staining pattern, either positive or negative, was observed in 48 of the 50 (96%) epithelial ovarian cancers. Two tumors had discordant staining between the fresh and paraffin specimens; one case stained positively only in the frozen tissue, whereas another exhibited nuclear staining only in paraffin. In both cases, multiple blocks of paraffin-embedded and cryopreserved tissue stained consistently.
Expression of pS3 Protein in Primary Breast Cancer
Overall, nine (36%) of the 25 primary breast cancers had strong nuclear staining in the malignant epithelial cells in both fresh and paraffin IHC assays (Table 1 ). An identical staining pattern with both techniques was observed in 23 of the 25 (92%) primary breast cancers. As in the ovarian cancer specimens, two discordant results between fresh and paraffin specimens were obtained. In one case, staining for p53 was seen only in the paraffin block, while in the other case staining was observed in the fresh-tissue sample. Staining of multiple blocks, at least two per case, confirmed these results.
Discussion
In this study we have demonstrated that immunodetection of p53 in paraffin-embedded material is reproducible and accurately reflects averexpression ofthe p53 protein in human tumors. In previous studies we have determined that nuclear reactivity with the MAb PAbl801 is indicative of p53 overexpression in breast and ovarian cancer (5, 9) . With this antibody, the same staining pattern (either positive or negative) was observed in 292% of formalin-fixed, paraffin-embedded ovarian and breast cancers when compared with the same tissues stained in a fresh-tissue IHC.
In both epithelial ovarian cancer and primary breast cancer (a total of 75 cases), the IHC assays for fresh and paraffin tissue were repeated in the four cases where the reactivity patterns did not correspond, and the same discordant results were obtained. In two cases a positive score was obtained in the paraffin IHC and not in the fresh IHC, and in the other two cases the fresh IHC was positive and not the paraffin.
In a total of seven tumors, one of the paraffin blocks had positive nuclear staining, whereas the other was negative. These cases were scored as positive, and in every instance the frozen tissue was also positive. There are a number of uncontrolled variables in processing tissues for paraffin embedding that might explain the different staining patterns between individual blocks: (a) the time lapse from excision to fixation; (b) the size of the tissue in the fixative; (c) the actual time that the tissue is in fixative; and (d) the temperature of the embedding station. All of these factors have a direct impact on the quality of antigen preservation. For these reasons we elected to stain at least two blocks per case, and we strongly recommend this to other investigators who may use this technique.
Several variables can also potentially influence the quality of staining in fresh-frozen tissues. These include: (a) a delay from excision to freezing; (b) the temperature of the freezing station; (c) whether a specimen is protected during the freezing process (e.g., gelatin or OCT Compound); and (d) stability and temperature of cryostorage. All of these factors can affect the quality of antigen preservation and the morphological appearance. Even given all of these potential problems, the degree of concordance between freshfrozen and formalin-fixed, paraffin-embedded tissues is very high (92-96%) in two common epithelial cancers. In addition, both fresh and paraffin materials appear to yield a low number of &-negative results, suggesting that studies using either method should produce comparable results.
Other investigators have detected p53 in formalin-fixed, paraffinembedded material (18) . In our present assay, incubation with antibody and avidin-biotin complex at 42'C permits completion of immunostaining in 5 hr rather than 2 days. In addition, detergent was not required to obtain comparable staining in paraffin-embedded and frozen material.
Mutations in the p53 gene that give rise to a more stable protein have been readily detected in a variety of common human cancers. The ability to detect overexpressed p53 protein using a reliable paraffin IHC assay allows access to well-characterized archival material and patient populations with long-term survival data. Examination of p53 in these cohorts will enable us to evaluate the relationship between mutations in this oncogene and the clinical and prognostic factors.
